SDS Biotech K.K.
株式会社エス・ディー・エス バイオテック
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4952
FY2020 · 2021-03-31
| Gross margin | 36.7% |
| Operating margin | 10.3% |
| Net margin | 11.4% |
| Return on equity | — |
| Return on assets | 9.0% |
| Revenue growth (YoY) | -3.1% |
| EPS (basic) | ¥175.14 |
| EPS growth (YoY) | 15.5% |
| Current ratio | 2.53x |
| Equity ratio | 50.8% |
| Book value / share | ¥1,020.15 |
| Free cash flow | 1,705 M |